Which of these answers includes an item that is not a part of the ASCVD risk calculation?

AAFP recommends starting statin therapy in a patient with ___ ASCVD 10-year risk in patients with diabetes and in those with LDL levels of 190 or higher

In patients with clinical ASCVD, reduce LDL with ___-intensity statin therapy.

In very high-risk ASCVD, use an LDL threshold of ___ mg/dL to consider addition of nonstatins to statin therapy

In patients with severe primary hypercholesterolemia (LDL ≥190 mg/dL) :

True/False: In patients 40 to 75yo with diabetes mellitus and LDL ≥70 mg/dL, start moderate-intensity statin therapy without calculating 10-year ASCVD risk.

In adults 40 to 75yo evaluated for primary ASCVD prevention:

In adults 40 to 75yo without diabetes mellitus and LDL ≥70 mg/dL, 10-year ASCVD risk of ≥___%, start a moderate-intensity statin if a discussion of treatment options favors statin therapy.

In adults 40 to 75yo without diabetes mellitus and 10-year risk of ___% to ___%, then the next step is to discuss risk-enhancing factors, and if have them, then favor initiation of statin therapy

In adults 40 to 75yo without diabetes mellitus and LDL levels ≥___to___ mg/dL, 10-year ASCVD risk of ≥7.5% to 19.9%, if a decision about statin therapy is uncertain, consider measuring CAC

After starting statin therapy, repeat lipid measurement ___to___ weeks after statin initiation or dose adjustment, repeat every ___to___ months as needed.

I'm sweating after all those numbers 😅, who is still awake?

63yo man with diabetes mellitus, no prior CVD or risk enhancers, not on statins...next step?

44yo South Asian female with rheumatoid arthritis, LDL 90, no diabetes mellitus, ASCVD risk score is 10%, you discuss risk-benefit with patient, what is the next step?

In a 58yo patient with clinical ASCVD, not at very high risk, not on statin, what is the next step?: